InsidersTradesSigma
Follow the NURIX THERAPEUTICS INC stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.7bn. The latest transaction was disclosed on 4 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: CHRISTINE RING. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
NURIX THERAPEUTICS INC es una empresa biofarmacéutica centrada en el desarrollo de terapias innovadoras basadas en la degradación de proteínas. Cotiza en el NASDAQ bajo el símbolo NRIX.